131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma
Status:
Unknown status
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
This drug is being developed to treat a type of brain cancer, glioma. This study was
developed to evaluate the safety, time to disease progression and survival rates after
treatment.